map2 Search Results


gene exp map2 mm00485230 m1  (Thermo Fisher)
87
Thermo Fisher gene exp map2 mm00485230 m1
Gene Exp Map2 Mm00485230 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 87/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/map2/pm33076743-61-26--1?v=Thermo+Fisher
Average 87 stars, based on 1 article reviews
gene exp map2 mm00485230 m1 - by Bioz Stars, 2026-07
87/100 stars
  Buy from Supplier
novusbiologicals nbp225156  (Novus Biologicals)
93
Novus Biologicals novusbiologicals nbp225156
Novusbiologicals Nbp225156, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/map2/pm39067446-1219-36-36?v=Novus+Biologicals
Average 93 stars, based on 1 article reviews
novusbiologicals nbp225156 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier
nb300  (Novus Biologicals)
96
Novus Biologicals nb300
Nb300, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/map2/pm36716149-201-45-42?v=Novus+Biologicals
Average 96 stars, based on 1 article reviews
nb300 - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
chicken anti map2  (AvesLabs)
98
AvesLabs chicken anti map2
Chicken Anti Map2, supplied by AvesLabs, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/map2/pmc08353115-47-22-30?v=AvesLabs
Average 98 stars, based on 1 article reviews
chicken anti map2 - by Bioz Stars, 2026-07
98/100 stars
  Buy from Supplier
28733 1 ap erk proteintech  (Proteintech)
96
Proteintech 28733 1 ap erk proteintech
28733 1 Ap Erk Proteintech, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/map2/pmc11610139__thnov14p7072s1-187-108-110?v=Proteintech
Average 96 stars, based on 1 article reviews
28733 1 ap erk proteintech - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
anti map2  (Santa Cruz Biotechnology)
96
Santa Cruz Biotechnology anti map2
Anti Map2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/map2/pm15585409-164-50-52?v=Santa+Cruz+Biotechnology
Average 96 stars, based on 1 article reviews
anti map2 - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
rabbit map2  (Novus Biologicals)
93
Novus Biologicals rabbit map2
A Workflow indicating that the 30-min treatment with tau oligomers was followed by different intervals of time (30 min, 1 hour, 24 hours, 7, or 14 days) before the fixation of human neuron cultures for experiments. B Confocal images of human neurons treated with oligomerized tau conjugated with Fluorescein-5-isothiocyanate (tau-FITC) (green) showed colocalization (white arrowheads) of tau-FITC with Synapsin (blue) and PSD-95 (red). Scale bar: 5 μm. C Representative confocal images of human neurons at 30 min, 1 hour and 24 hours after the 30 min exposure with oligomerized tau-FITC as described in A . Scale bar: 5 μm. D Quantification of the integrated intensity of tau-FITC fluorescence at synapses in human neurons that were treated with oligomerized tau-FITC for 30 min and fixed at different time points A (n = 12 images/group; ** p < 0.01, *** p < 0.001, one-way ANOVA, Bonferroni post hoc analyses). E, F Representative images of NeuN immunolabeling, as a neuronal marker, in vehicle-treated control neurons and in neurons at either ( E ) 7 or ( F ) 14 days after the 30-min exposure to tau oligomers. The density of NeuN-positive cells in the cultures was calculated and compared with or without tau oligomer exposure (n = 12 images/group; no significant difference, Unpaired Student’s t -test). Scale bar: 100 mm. G, H Representative confocal images of <t>MAP2</t> immunostaining in neurons at ( G ) 7 or ( H ) 14 days after the 30-min tau oligomer treatment and in neurons treated with vehicle control. Scale bars: 20 μm. The intensity of MAP2 immunolabeling in dendrites of human neurons was quantified at ( G ) 7 days (n = 12 images/group; no significant difference, Unpaired Student’s t -test) and ( H ) 14 days (n = 12 images/group; *** p < 0.001, Unpaired Student’s t -test) post-oligomer exposure. Values are given as means ± SEM.
Rabbit Map2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/map2/bio_rxiv__2025__09__19__677215-95-58-67?v=Novus+Biologicals
Average 93 stars, based on 1 article reviews
rabbit map2 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier
microtubule associated protein 2 map2  (Neuromics)
93
Neuromics microtubule associated protein 2 map2
A Workflow indicating that the 30-min treatment with tau oligomers was followed by different intervals of time (30 min, 1 hour, 24 hours, 7, or 14 days) before the fixation of human neuron cultures for experiments. B Confocal images of human neurons treated with oligomerized tau conjugated with Fluorescein-5-isothiocyanate (tau-FITC) (green) showed colocalization (white arrowheads) of tau-FITC with Synapsin (blue) and PSD-95 (red). Scale bar: 5 μm. C Representative confocal images of human neurons at 30 min, 1 hour and 24 hours after the 30 min exposure with oligomerized tau-FITC as described in A . Scale bar: 5 μm. D Quantification of the integrated intensity of tau-FITC fluorescence at synapses in human neurons that were treated with oligomerized tau-FITC for 30 min and fixed at different time points A (n = 12 images/group; ** p < 0.01, *** p < 0.001, one-way ANOVA, Bonferroni post hoc analyses). E, F Representative images of NeuN immunolabeling, as a neuronal marker, in vehicle-treated control neurons and in neurons at either ( E ) 7 or ( F ) 14 days after the 30-min exposure to tau oligomers. The density of NeuN-positive cells in the cultures was calculated and compared with or without tau oligomer exposure (n = 12 images/group; no significant difference, Unpaired Student’s t -test). Scale bar: 100 mm. G, H Representative confocal images of <t>MAP2</t> immunostaining in neurons at ( G ) 7 or ( H ) 14 days after the 30-min tau oligomer treatment and in neurons treated with vehicle control. Scale bars: 20 μm. The intensity of MAP2 immunolabeling in dendrites of human neurons was quantified at ( G ) 7 days (n = 12 images/group; no significant difference, Unpaired Student’s t -test) and ( H ) 14 days (n = 12 images/group; *** p < 0.001, Unpaired Student’s t -test) post-oligomer exposure. Values are given as means ± SEM.
Microtubule Associated Protein 2 Map2, supplied by Neuromics, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/map2/pmc05154837-123-21-27?v=Neuromics
Average 93 stars, based on 1 article reviews
microtubule associated protein 2 map2 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier
map2 17490 1 ap  (Proteintech)
96
Proteintech map2 17490 1 ap
A Workflow indicating that the 30-min treatment with tau oligomers was followed by different intervals of time (30 min, 1 hour, 24 hours, 7, or 14 days) before the fixation of human neuron cultures for experiments. B Confocal images of human neurons treated with oligomerized tau conjugated with Fluorescein-5-isothiocyanate (tau-FITC) (green) showed colocalization (white arrowheads) of tau-FITC with Synapsin (blue) and PSD-95 (red). Scale bar: 5 μm. C Representative confocal images of human neurons at 30 min, 1 hour and 24 hours after the 30 min exposure with oligomerized tau-FITC as described in A . Scale bar: 5 μm. D Quantification of the integrated intensity of tau-FITC fluorescence at synapses in human neurons that were treated with oligomerized tau-FITC for 30 min and fixed at different time points A (n = 12 images/group; ** p < 0.01, *** p < 0.001, one-way ANOVA, Bonferroni post hoc analyses). E, F Representative images of NeuN immunolabeling, as a neuronal marker, in vehicle-treated control neurons and in neurons at either ( E ) 7 or ( F ) 14 days after the 30-min exposure to tau oligomers. The density of NeuN-positive cells in the cultures was calculated and compared with or without tau oligomer exposure (n = 12 images/group; no significant difference, Unpaired Student’s t -test). Scale bar: 100 mm. G, H Representative confocal images of <t>MAP2</t> immunostaining in neurons at ( G ) 7 or ( H ) 14 days after the 30-min tau oligomer treatment and in neurons treated with vehicle control. Scale bars: 20 μm. The intensity of MAP2 immunolabeling in dendrites of human neurons was quantified at ( G ) 7 days (n = 12 images/group; no significant difference, Unpaired Student’s t -test) and ( H ) 14 days (n = 12 images/group; *** p < 0.001, Unpaired Student’s t -test) post-oligomer exposure. Values are given as means ± SEM.
Map2 17490 1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/map2/pmc08980034__42003_2022_3263_MOESM10_ESM-24-70-72?v=Proteintech
Average 96 stars, based on 1 article reviews
map2 17490 1 ap - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
microtubule  (Boster Bio)
94
Boster Bio microtubule
A Workflow indicating that the 30-min treatment with tau oligomers was followed by different intervals of time (30 min, 1 hour, 24 hours, 7, or 14 days) before the fixation of human neuron cultures for experiments. B Confocal images of human neurons treated with oligomerized tau conjugated with Fluorescein-5-isothiocyanate (tau-FITC) (green) showed colocalization (white arrowheads) of tau-FITC with Synapsin (blue) and PSD-95 (red). Scale bar: 5 μm. C Representative confocal images of human neurons at 30 min, 1 hour and 24 hours after the 30 min exposure with oligomerized tau-FITC as described in A . Scale bar: 5 μm. D Quantification of the integrated intensity of tau-FITC fluorescence at synapses in human neurons that were treated with oligomerized tau-FITC for 30 min and fixed at different time points A (n = 12 images/group; ** p < 0.01, *** p < 0.001, one-way ANOVA, Bonferroni post hoc analyses). E, F Representative images of NeuN immunolabeling, as a neuronal marker, in vehicle-treated control neurons and in neurons at either ( E ) 7 or ( F ) 14 days after the 30-min exposure to tau oligomers. The density of NeuN-positive cells in the cultures was calculated and compared with or without tau oligomer exposure (n = 12 images/group; no significant difference, Unpaired Student’s t -test). Scale bar: 100 mm. G, H Representative confocal images of <t>MAP2</t> immunostaining in neurons at ( G ) 7 or ( H ) 14 days after the 30-min tau oligomer treatment and in neurons treated with vehicle control. Scale bars: 20 μm. The intensity of MAP2 immunolabeling in dendrites of human neurons was quantified at ( G ) 7 days (n = 12 images/group; no significant difference, Unpaired Student’s t -test) and ( H ) 14 days (n = 12 images/group; *** p < 0.001, Unpaired Student’s t -test) post-oligomer exposure. Values are given as means ± SEM.
Microtubule, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/map2/ppr0308382-91-45-50?v=Boster+Bio
Average 94 stars, based on 1 article reviews
microtubule - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier
mouse anti map2  (Novus Biologicals)
93
Novus Biologicals mouse anti map2
A Workflow indicating that the 30-min treatment with tau oligomers was followed by different intervals of time (30 min, 1 hour, 24 hours, 7, or 14 days) before the fixation of human neuron cultures for experiments. B Confocal images of human neurons treated with oligomerized tau conjugated with Fluorescein-5-isothiocyanate (tau-FITC) (green) showed colocalization (white arrowheads) of tau-FITC with Synapsin (blue) and PSD-95 (red). Scale bar: 5 μm. C Representative confocal images of human neurons at 30 min, 1 hour and 24 hours after the 30 min exposure with oligomerized tau-FITC as described in A . Scale bar: 5 μm. D Quantification of the integrated intensity of tau-FITC fluorescence at synapses in human neurons that were treated with oligomerized tau-FITC for 30 min and fixed at different time points A (n = 12 images/group; ** p < 0.01, *** p < 0.001, one-way ANOVA, Bonferroni post hoc analyses). E, F Representative images of NeuN immunolabeling, as a neuronal marker, in vehicle-treated control neurons and in neurons at either ( E ) 7 or ( F ) 14 days after the 30-min exposure to tau oligomers. The density of NeuN-positive cells in the cultures was calculated and compared with or without tau oligomer exposure (n = 12 images/group; no significant difference, Unpaired Student’s t -test). Scale bar: 100 mm. G, H Representative confocal images of <t>MAP2</t> immunostaining in neurons at ( G ) 7 or ( H ) 14 days after the 30-min tau oligomer treatment and in neurons treated with vehicle control. Scale bars: 20 μm. The intensity of MAP2 immunolabeling in dendrites of human neurons was quantified at ( G ) 7 days (n = 12 images/group; no significant difference, Unpaired Student’s t -test) and ( H ) 14 days (n = 12 images/group; *** p < 0.001, Unpaired Student’s t -test) post-oligomer exposure. Values are given as means ± SEM.
Mouse Anti Map2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/map2/pmc05822864-110-9-14?v=Novus+Biologicals
Average 93 stars, based on 1 article reviews
mouse anti map2 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

Image Search Results


A Workflow indicating that the 30-min treatment with tau oligomers was followed by different intervals of time (30 min, 1 hour, 24 hours, 7, or 14 days) before the fixation of human neuron cultures for experiments. B Confocal images of human neurons treated with oligomerized tau conjugated with Fluorescein-5-isothiocyanate (tau-FITC) (green) showed colocalization (white arrowheads) of tau-FITC with Synapsin (blue) and PSD-95 (red). Scale bar: 5 μm. C Representative confocal images of human neurons at 30 min, 1 hour and 24 hours after the 30 min exposure with oligomerized tau-FITC as described in A . Scale bar: 5 μm. D Quantification of the integrated intensity of tau-FITC fluorescence at synapses in human neurons that were treated with oligomerized tau-FITC for 30 min and fixed at different time points A (n = 12 images/group; ** p < 0.01, *** p < 0.001, one-way ANOVA, Bonferroni post hoc analyses). E, F Representative images of NeuN immunolabeling, as a neuronal marker, in vehicle-treated control neurons and in neurons at either ( E ) 7 or ( F ) 14 days after the 30-min exposure to tau oligomers. The density of NeuN-positive cells in the cultures was calculated and compared with or without tau oligomer exposure (n = 12 images/group; no significant difference, Unpaired Student’s t -test). Scale bar: 100 mm. G, H Representative confocal images of MAP2 immunostaining in neurons at ( G ) 7 or ( H ) 14 days after the 30-min tau oligomer treatment and in neurons treated with vehicle control. Scale bars: 20 μm. The intensity of MAP2 immunolabeling in dendrites of human neurons was quantified at ( G ) 7 days (n = 12 images/group; no significant difference, Unpaired Student’s t -test) and ( H ) 14 days (n = 12 images/group; *** p < 0.001, Unpaired Student’s t -test) post-oligomer exposure. Values are given as means ± SEM.

Journal: bioRxiv

Article Title: Tau oligomers modulate synapse fate by eliciting progressive bipartite synapse dysregulation and synapse loss

doi: 10.1101/2025.09.19.677215

Figure Lengend Snippet: A Workflow indicating that the 30-min treatment with tau oligomers was followed by different intervals of time (30 min, 1 hour, 24 hours, 7, or 14 days) before the fixation of human neuron cultures for experiments. B Confocal images of human neurons treated with oligomerized tau conjugated with Fluorescein-5-isothiocyanate (tau-FITC) (green) showed colocalization (white arrowheads) of tau-FITC with Synapsin (blue) and PSD-95 (red). Scale bar: 5 μm. C Representative confocal images of human neurons at 30 min, 1 hour and 24 hours after the 30 min exposure with oligomerized tau-FITC as described in A . Scale bar: 5 μm. D Quantification of the integrated intensity of tau-FITC fluorescence at synapses in human neurons that were treated with oligomerized tau-FITC for 30 min and fixed at different time points A (n = 12 images/group; ** p < 0.01, *** p < 0.001, one-way ANOVA, Bonferroni post hoc analyses). E, F Representative images of NeuN immunolabeling, as a neuronal marker, in vehicle-treated control neurons and in neurons at either ( E ) 7 or ( F ) 14 days after the 30-min exposure to tau oligomers. The density of NeuN-positive cells in the cultures was calculated and compared with or without tau oligomer exposure (n = 12 images/group; no significant difference, Unpaired Student’s t -test). Scale bar: 100 mm. G, H Representative confocal images of MAP2 immunostaining in neurons at ( G ) 7 or ( H ) 14 days after the 30-min tau oligomer treatment and in neurons treated with vehicle control. Scale bars: 20 μm. The intensity of MAP2 immunolabeling in dendrites of human neurons was quantified at ( G ) 7 days (n = 12 images/group; no significant difference, Unpaired Student’s t -test) and ( H ) 14 days (n = 12 images/group; *** p < 0.001, Unpaired Student’s t -test) post-oligomer exposure. Values are given as means ± SEM.

Article Snippet: Primary antibodies used for western blot and immunocytochemistry were: Tau5 (AB_80579, Abcam), Streptavin HRP (S911, Invitrogen), GAPDH (MAB374, Sigma), Rabbit FLAG (F7425, Sigma), Mouse FLAG (F3165, Sigma), PSD-95 (MA1046, ThermoFisher), GluA2/3 (AB1506, MilliporeSigma), Cy3 Streptavidin (AB_2337244, Jackson Immunoresearch), Mouse vGluT1 (MAB5502, MilliporeSigma), Guinea Pig vGluT1 (AB5905, MilliporeSigma), GluA1 (ABN241, MilliporeSigma), GluN1 (114 011, SynapticSystems), Synapsin (5297S, Cell Signaling), Rabbit MAP2 (4542S, Cell Signaling), Chicken MAP2 (NB300 213, Novus Biologicals), NeuN (AB177487, Abcam), GFAP (PA110004, Invitrogen) Secondary antibodies used were: Anti-mouse Alexa Fluor 488 (115-545-166, Jackson Immunoresearch), Anti-guinea pig Alexa Fluor 546 (A-11074, Life Technologies), Anti-mouse Alexa Fluor 546 (A-11030, Invitrogen), Anti-rabbit Alexa Fluor 647 (111-605-144, Jackson Immunoresearch), Anti-chicken Alexa Fluor 647 (A32933, Invitrogen)

Techniques: Fluorescence, Immunolabeling, Marker, Control, Immunostaining